Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1732 USD | -1.00% | -0.69% | +139.70% |
May. 09 | Vivos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 18 | Vivos Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 1
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Brachytherapy Devices
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -46.57% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -46.57% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Korenko
CEO | Chief Executive Officer | 77 | 16-11-30 |
Carlton Cadwell
CHM | Chairman | 79 | 05-12-31 |
Michael Pollack
DFI | Director of Finance/CFO | 57 | 18-11-30 |
Chief Tech/Sci/R&D Officer | - | - | |
Chief Tech/Sci/R&D Officer | 67 | - | |
Fu-Min Su
PRN | Corporate Officer/Principal | - | 06-12-31 |
Alan R. Merkle
LAW | General Counsel | - | - |
Donald A. Ludwig
PRN | Corporate Officer/Principal | - | - |
General Counsel | 76 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Carlton Cadwell
CHM | Chairman | 79 | 05-12-31 |
Michael Korenko
CEO | Chief Executive Officer | 77 | 16-11-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 200,363 | 0 | 0 | 95.15 % |
Stock B | 0 | 2,071,007 | 0 | 0 | |
Stock C | 1 | 401,033,867 | 381,601,298 ( 95.15 %) | 11,000,000 ( 2.743 %) | |
Stock D | 0 | 385,302 | 0 | 0 |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+139.70% | 71.18M | |
-11.43% | 13.72B | |
-44.31% | 2.55B | |
-13.72% | 2.43B | |
-21.19% | 1.31B | |
-.--% | 1.12B | |
+94.36% | 515M | |
+23.08% | 453M | |
+31.39% | 285M | |
-11.03% | 203M |
- Stock Market
- Equities
- RDGL Stock
- Company Vivos Inc.